Characterization of vascular gene transfer using a novel cationic lipid

Journal of Surgical Research

Volumn 85, Issue 2, 1999, Pages 339-345

  Matsumura, Jon S ^a   Kim, Roger ^a   Shively, Vera P ^a   MacDonald, Robert C ^b   Pearce, William H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYLDIOLEOYLPHOSPHATIDYLCHOLINIUM; LIPID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LIPID ANALYSIS; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR DISEASE;

EID: 0032799734     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5678     Document Type: Article

References (24)

1. Mann M. J., Whittemore A. D., Donaldson M. C., Belkin M. A., Conte M. S., Orav J., Polak J. F., Dzau V. J. The PREVENT trial of vein graft genetic engineering: preliminary molecular and clinical findings. Circulation. 98:1998;I321.
2. Chang M. W., Barr E., Seltzer J., Jiang Y.-Q., Nabel G. J., Nabel E. G., Parmacek M. S., Leiden J. M. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 267:1995;518.
3. Moawad, J., Schwartz, L., Gewertz, B. L., Chang, M. W., and Leiden, J. M.Efficiency of adenoviral-mediated gene transfer in experimental vein grafts. Program Book, 21st Annual Meeting Midwestern Vascular Surgery Society, 1997. Pp. 30-31.
4. Zelenock J. A., Welling T. H., Sarkar R., Gordon D. G., Messina L. M. Improved retroviral transduction efficiency of vascular cells in vitro and in vivo during clinically relevant incubation periods using centrifugation to increase viral titers. J. Vasc. Surg. 26:1997;119.
5. Dichek D. A., Neville R. F., Zwiebel J. A., Freeman S. M., Leon M. B., Anderson W. F. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 80:1989;1347.
6. Ekhterae D., Stanley J. C. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endotelial and vascular smooth muscle cells. J. Vasc. Surg. 21:1995;953.
7. Sugawara Y., Sakata Y., Minowada S., Hamada H., Yoshida Y., Sato O., Deguchi J., Kimura H., Namba T., Makuuchi M., Miyata T. Adenovirus-mediated transfer of tissue-type plasminogen activator gene to human endothelial cells. Surgery. 122:1997;91.
8. Rade J. J., Schulick A. H., Virmani R., Dichek D. A. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nature Med. 2:1996;293.
9. Vale P. R., Wuensch D. I., Guenter F. R., Rosenfield K. M., Schainfeld R. M., Isner J. M. Arterial gene therapy for inhibiting restenosis in patients with claudication undergoing superficial femoral artery angioplasty. Circulation. 98:1998;I66.
10. Laitinen M., Hartikainen J., Eranen J., Kiviniemi M., Hiltunen M. O., Laakso M., Yla-Herttuala S. Catheter-mediated VEGF gene transfer to human coronary arteries after angioplasty. Safety results from Phase I Kuopio angioplasty gene transfer trial. Circulation. 98:1998;I322.
11. Leclerc G., Gal D., Takeshita S., Nikol S., Weir L., Isner J. M. Percutaneous arterial gene transfer in a rabbit model. J. Clin. Invest. 90:1992;936.
12. Takeshita S., Gal D., Leclerc G., Pickering G., Riessen R., Weir L., Isner J. M. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. J. Clin. Invest. 93:1994;652.
13. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 97:1998;1114.
14. Channon K. M., Youngblood S. A., Olmez E., Shetty G. A., Blazing M. A., Qian H. S., Neplioueva V., George S. E. Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: Impact on transgene expression and endothelial function. Circ. Res. 82:1998;1253.
15. Yang Y., Nunes F. A., Berencsi K., Furth E. E., Gonczol E., Wilson J. M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407.
16. MacDonald, R. C, Ashley, G. W, Shida, M. M, Qiu, R, Levisay, P. C, Lahiri, M. K, Jones, R. D, Baker, K. A, Rosenzweig, H. S, Rakhmanova, V. A, Choi, K. L, and, McIntosh, T. J. Phosphatidylcholinium compounds: A new class of cationic phospholipids with transfection activity and unusual physical properties. In preparation.
17. Keogh M.-C., Chen D., Lupu F., Shaper N., Schmitt J. F., Kakkar V. V., Lemoine N. R. High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid-DNA complex. Gene Ther. 4:1997;162.
18. Boussif O., Zanta M. A., Behr J.-P. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 3:1996;1074.
19. Pickering J. G., Jekanowski J., Weir L., Takeshita S., Losordo D. W., Isner J. M. Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation. 89:1994;13.
20. Marin M. L., Veith F. J., Cynamon J. Human transluminally placed endovascular stented grafts: Preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J. Vasc. Surg. 21:1995;595.
21. Felgner P. L., Gadak T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop J. P., Ringold G. M., Danielson M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413.
22. Nabel E. G., Yang Z. Y., Plautz G., Forough R., Zhan X., Haudenschild C. C., Nabel G. J. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature. 91:1993;1822.
23. Rekhter M. D., Shah N., Simari R. D., Work C., Kim J.-S., Nabel G. J., Nabel E. G., Gordon D. Graft permeabilization facilitates gene therapy of transplant arteriosclerosis in a rabbit model. Circulation. 98:1998;1335.
24. Ooboshi H., Rios C. D., Chu Y., Christenson S. D., Faraci F. M., Davidson B. L., Heistad D. D. Augmented adenovirus-mediated gene transfer to atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17:1997;1786.